期刊文献+

皮革样膀胱癌的临床特点分析

Clinical Features and Diagnosis of Encrusted Bladder Cancer
下载PDF
导出
摘要 膀胱癌是发病率及死亡率均较高的泌尿系统恶性肿瘤,向膀胱腔内突起的肿物是临床诊断膀胱癌的重要特征。然而,皮革样膀胱癌患者(EBC)并不表现为向膀胱腔内突起,临床上容易漏诊、误诊。北京大学人民医院泌尿外科于2015年7月至2016年2月收治了4例EBC患者,均为男性,年龄40~77岁。临床表现均以下尿路症状为主,表现为尿频、尿急、夜尿增多,单次排尿量减少,伴或不伴排尿困难。影像学检查示膀胱壁弥漫增厚,均未见外突性膀胱占位。3例患者行尿动力学检查,膀胱最大容量41~128ml。1例患者出现肉眼血尿,2例患者镜下血尿,1例患者无血尿膀胱壁增厚。膀胱镜检查未见肿物,最终通过反复活检或术中冰冻确诊为膀胱癌。 Bladder cancer is a urological malignant tumor with high morbidity and mortality. Masses protruding into the bladder cavity is an important feature for clinical diagnosis of bladder cancer. However,patients with encrusted bladder cancer(EBC)do not present with masses protruding into the bladder cavity and thus this malignancy is often misdiagnosed. Four patients were admitted in Peking University People ’s Hospital from July 2015 to February 2017. All of them were males aged 40 to 77 years(mean:58 years). Patients were mainly manifested as frequent urination,urgency,nocturia,and decreased bladder capacity,with or without difficulty of voiding.Although the bladder walls were markedly thickened,there was no obvious mass on imaging scans. Three patients received urodynamic test,which showed the maximum capacity of the bladder was 41 to 128 ml(mean:91 ml). One patient presented with gross hematuria,two patients presented with microscopic hematuria,and the remaining one patient had no hematuria. No mass was observed by cystoscopy. All of the patients were diagnosed with bladder cancer by repeated biopsy or intraoperative frozen section analysis.
作者 张维宇 王焕瑞 胡浩 王起 张晓鹏 许克新 ZHANG Weiyu;WANG Huanrui;HU Hao;WANG Qi;ZHANG Xiaopeng;XU Kexin(Department of Urology,Peking University People’s Hospital,Beijing 100044,China)
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2019年第3期430-434,共5页 Acta Academiae Medicinae Sinicae
关键词 皮革样膀胱癌 下尿路症状 临床特点 encrusted bladder cancer lower urinary tract symptoms clinical features
  • 相关文献

参考文献5

二级参考文献42

  • 1邵晋凯,黄立坤,冯贵生,问晓东,曹金红.NMP22在膀胱癌早期诊断中的临床研究[J].中华泌尿外科杂志,2006,27(S1):48-49. 被引量:7
  • 2辛殿祺,由然,丁义,刘凌琪,那彦群.尿核基质蛋白22浓度与膀胱移行细胞癌病理分级分期关系的研究[J].中华外科杂志,2006,44(10):681-683. 被引量:4
  • 3Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemo- therapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer [J]. N Engl J Med, 2003, 349: 859- 866.
  • 4Griffiths G, Hall R, Sylvester R, et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblas- tine ehemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial [J]. J Clin Ocol, 2011, 29: 2171-2177.
  • 5Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J]. CA Cancer J Clin, 2012, 62: 10-29.
  • 6Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer [J]. Eur Urol, 2013, 63: 234-241.
  • 7Cheung G, Sahai A, Billia M, et al. Recent advances in the di- agnosis and treatment of bladder cancer [ J/CD]. BMC Med, 2013, 11:13.
  • 8Benner C, Greenberg M, Sbepard N, et al. The natural history of symptoms and distress for patients and families following cystecto- my for treatment of muscle-invasive bladder cancer [ J/OL ]. J Urol, 2013 [ 2013-12-14 ]. http://www, jurology, corn/article/ S0022-5347 ( 13 ) 05840-0/pdf. [ published online ahead of print October 24,2013 ].
  • 9Rogers CG, Palapattu GS, Shariat SF, et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carci- noma of the bladder compared to transitional cell carcinoma of the bladder [ J]. J Urol, 2006, 175 : 2048-2053.
  • 10Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data [ J ]. Eur Urol, 2005, 48: 189-201.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部